Miami, FL – December 12, 2019 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Therapeutics Solutions International, Inc. (OTC Pink: TSOI).

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to target cancers, enhance maternal and fetal health, and fight periodontal disease, as well as for daily health. Its flagship product is ProJuvenol, a synergistic blend of complex anti-aging ingredients based upon pterostilbene to promote cellular rejuvenation and healthy functionality. The company also focuses on the manufacture of devices to treat patients with obstructive sleep apnea.

Average daily volume for TSOI 1.3 million shares. Today’s news has caused the volume to increase to over 45.7 million shares in the morning hours of trading.

Therapeutics Solutions International, Inc.  Press Release:

OCEANSIDE, California, Dec. 12, 2019 /PRNewswire/ — Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announces today the signing of a Master Sales Agreement with Tiva Bio to distribute the nutraceutical line of products developed by TSOI.

Products to be included in the Master Sales Agreement currently consists of NanoStilbene, NeuroStilbene, NanoPSA, Nano Plus, Nano Cannabidiol, and ProJuvenol. Future products will be added to the Master List as commercialized.

“After more than a year of discussions, collaborations, and demonstrating the potent properties of our products with Wes Chandler and his Team, we are very excited to execute this sales agreement with our great friends at Tiva Bio, a Wes Chandler Company, focused on biotechnology, their mission is to discover, develop, and bring to market novel products that are designed to provide relief to an array of symptoms including CTE, pain, nausea, anxiety, and inflammation,” said Timothy Dixon, President, and CEO of TSOI. “The Team Wes has assembled in areas of science, marketing, and branding is second to none. We are fortunate to work with such a well-fitted and synergistic partner. This agreement only marks the beginning of a long and beneficial relationship focused on providing preventative and treatment approaches to chronic traumatic encephalopathy.”

About Therapeutic Solutions International, Inc.

Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. Immune modulation refers to the ability to upregulate (make more active) or downregulate (make less active) one’s immune system. The Company’s corporate website is at www.therapeuticsolutionsint.com and our e-commerce is at www.youcanordernow.com and for additional info on NanoStilbene visit www.mynanostilbene.com.

About Tiva Bio

Tiva Bio is a biotechnology company dedicated to the development of science-based products. We bring scientific expertise to product formulation and dosing of plant-based therapeutics to improve customers’ quality of life, health, and well-being.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our SEC filings. To the extent that statements in this press release are not strictly historical, including statements as to product launch timing, revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future collaboration agreements, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

Contact Information:

Therapeutic Solutions International, Inc.

Timothy Dixon

+1(760)-295-7208

ir@tsoimail.com

View original content:http://www.prnewswire.com/news-releases/therapeutic-solutions-international-enters-into-multi-million-dollar-master-sales-agreement-with-tiva-bio-300974030.html

SOURCE Therapeutic Solutions International, Inc.

/Web site: http://www.youcanordernow.com 


About EmergingGrowth.com

EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies.  Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization.  We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth.  Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community.  Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  EmergingGrowth.com, or its associates may have a position either long or short in any company mentioned herein. Please read our full disclosure, which can be found here, http://emerginggrowth.com/disclosure/. Please consult an investment professional before investing in anything viewed within this article or any other portion of EmergingGrowth.com. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

Add a Comment to this Post

comments